Virus safety of human blood, plasma, and derived products

This publication has 22 references indexed in Scilit:

• Human parvovirus B19-associated disease in bone marrow transplantation
  Infection, 1999
• Propagation of a Human Herpesvirus from AIDS-Associated Kaposi's Sarcoma
  New England Journal of Medicine, 1997
• Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
  Proceedings of the National Academy of Sciences, 1993
• The Risk of Transfusion-Transmitted Infection
  New England Journal of Medicine, 1992
• PREVENTION OF PRIMARY CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION BY USING LEUKOCYTE-POOR RANDOM BLOOD PRODUCTS FROM CYTOMEGALOVIRUS-UNSCREENED BLOOD-BANK DONORS
  Transplantation, 1990
• Chronic non‐A, non‐B hepatitis developed after transfusions, illicit self‐injections or sporadically. Outcome during long‐term follow‐up – a comparison
  Liver International, 1989
• Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine
  Vaccine, 1988
• Posttransfusion hepatitis type A
  JAMA, 1983
• Serologic Markers of Hepatitis B Virus Infection
  Annual Review of Medicine, 1981
• Antibodies to Epstein-Barr Virus-Associated Nuclear Antigen in Infectious Mononucleosis
  The Journal of Infectious Diseases, 1974